Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Apolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents.

Osei-Hwedieh DO, Amar M, Sviridov D, Remaley AT.

Pharmacol Ther. 2011 Apr;130(1):83-91. doi: 10.1016/j.pharmthera.2010.12.003. Epub 2010 Dec 21.

2.
3.

Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal.

Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Datta G, Garber D, Fogelman AM.

Curr Opin Lipidol. 2004 Dec;15(6):645-9. Review.

PMID:
15529023
4.

Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides.

Anantharamaiah GM, Mishra VK, Garber DW, Datta G, Handattu SP, Palgunachari MN, Chaddha M, Navab M, Reddy ST, Segrest JP, Fogelman AM.

J Lipid Res. 2007 Sep;48(9):1915-23. Epub 2007 Jun 14. Review.

5.

The dual nature of HDL: Anti-Inflammatory and pro-Inflammatory.

Namiri-Kalantari R, Gao F, Chattopadhyay A, Wheeler AA, Navab KD, Farias-Eisner R, Reddy ST.

Biofactors. 2015 May 6;41(3):153-9. doi: 10.1002/biof.1205. Epub 2015 Jun 13. Review.

PMID:
26072738
6.

Biological properties of apolipoprotein a-I mimetic peptides.

Getz GS, Wool GD, Reardon CA.

Curr Atheroscler Rep. 2010 Mar;12(2):96-104. doi: 10.1007/s11883-010-0097-4. Review.

7.

Atherosclerosis and vascular disease: effects of peptide mimetics of apolipoproteins.

Garber DW, Handattu SP, Datta G, Mishra VK, Gupta H, White CR, Anantharamaiah GM.

Curr Pharm Biotechnol. 2006 Aug;7(4):235-40. Review.

PMID:
16918400
8.

Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis.

Sherman CB, Peterson SJ, Frishman WH.

Cardiol Rev. 2010 May-Jun;18(3):141-7. doi: 10.1097/CRD.0b013e3181c4b508. Review.

PMID:
20395699
9.

Oral amphipathic peptides as therapeutic agents.

Reddy ST, Anantharamaiah GM, Navab M, Hama S, Hough G, Grijalva V, Garber DW, Datta G, Fogelman AM.

Expert Opin Investig Drugs. 2006 Jan;15(1):13-21. Review.

PMID:
16370930
10.

The effect of apolipoprotein mimetic peptides in inflammatory disorders other than atherosclerosis.

Navab M, Anantharamaiah GM, Fogelman AM.

Trends Cardiovasc Med. 2008 Feb;18(2):61-6. doi: 10.1016/j.tcm.2007.12.006. Review.

11.

Apolipoprotein A-I mimetics and high-density lipoprotein function.

Gordon SM, Davidson WS.

Curr Opin Endocrinol Diabetes Obes. 2012 Apr;19(2):109-14. doi: 10.1097/MED.0b013e32835056d4. Review.

PMID:
22278086
12.

Apoprotein A-I mimetic peptides and their potential anti-atherogenic mechanisms of action.

Getz GS, Wool GD, Reardon CA.

Curr Opin Lipidol. 2009 Jun;20(3):171-5. doi: 10.1097/MOL.0b013e32832ac051. Review.

PMID:
19373084
13.

Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis.

Smith JD.

Curr Opin Investig Drugs. 2010 Sep;11(9):989-96. Review.

14.

Recent advances on the antiatherogenic effects of HDL-derived proteins and mimetic peptides.

Petraki MP, Mantani PT, Tselepis AD.

Curr Pharm Des. 2009;15(27):3146-66. Review.

PMID:
19754388
15.

Lipid-free Apolipoprotein A-I Structure: Insights into HDL Formation and Atherosclerosis Development.

Mei X, Atkinson D.

Arch Med Res. 2015 Jul;46(5):351-60. doi: 10.1016/j.arcmed.2015.05.012. Epub 2015 Jun 3. Review.

16.

Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins.

Imaizumi S, Navab M, Morgantini C, Charles-Schoeman C, Su F, Gao F, Kwon M, Ganapathy E, Meriwether D, Farias-Eisner R, Fogelman AM, Reddy ST.

Circ J. 2011;75(7):1533-8. Epub 2011 May 28. Review.

17.

Drugs in development: targeting high-density lipoprotein metabolism and reverse cholesterol transport.

Duffy D, Rader DJ.

Curr Opin Cardiol. 2005 Jul;20(4):301-6. Review.

PMID:
15956827
18.

Acute effects of high-density lipoproteins: biochemical basis and clinical findings.

Chiesa G, Parolini C, Sirtori CR.

Curr Opin Cardiol. 2008 Jul;23(4):379-85. doi: 10.1097/HCO.0b013e3283007ccd. Review.

PMID:
18520723
19.

Structure and function of HDL mimetics.

Navab M, Shechter I, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Fogelman AM.

Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):164-8. doi: 10.1161/ATVBAHA.109.187518. Epub 2009 Jul 16. Review.

20.

High density lipoprotein structure-function and role in reverse cholesterol transport.

Lund-Katz S, Phillips MC.

Subcell Biochem. 2010;51:183-227. doi: 10.1007/978-90-481-8622-8_7. Review.

Supplemental Content

Support Center